← Scroll for more →
Mineralys Therapeutics, Inc. (MLYS)
Pharmaceutical Preparations
Latest Price
$21.13
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
6.68
P/B Ratio
3.16
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Catalys Pacific, LLC | 7.90M | $213.0M | 8.95% | -- | 2026-06-30 |
| RA Capital Management, L.P. | 7.69M | $207.0M | 8.71% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.89M | $158.0M | 6.66% | +1.41M | 2026-06-30 |
| Samsara Biocapital, LLC | 5.87M | $158.0M | 6.65% | -- | 2026-06-30 |
| FMR LLC | 4.51M | $121.0M | 5.11% | -349.4K | 2026-06-30 |
| State Street Corp | 4.14M | $111.0M | 4.69% | +1.21M | 2026-06-30 |
| Deerfield Management Company, L.P. | 3.96M | $106.0M | 4.48% | -- | 2026-06-30 |
| Armistice Capital, LLC | 2.78M | $74.0M | 3.14% | +1.60M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.76M | $74.0M | 3.12% | +302.4K | 2026-06-30 |
| Laurion Capital Management LP | 2.51M | $67.0M | 2.84% | +274.1K | 2026-06-30 |